xtremepicks.com: www.Xtremepicks.Com: Xtremepicks Alerts November 17, 2009 : CEMI, ICPR, VIVK and HLXW

Chembio Diagnostics, Inc. (OTCBB: CEMI | Quote | Chart | News | PowerRating) trading at $0.35 per share on trading volume of 47,151 shares.

In a press release out on November 17, Chembio Diagnostics to Present at the FDA Blood Products Advisory Committee on November 17, 2009

Company to Present Features of Its DPP(R) HIV 1 & 2 Oral Fluid Screening Assay in Meeting to Discuss Over-the-Counter Home-Use HIV Test Kits

MEDFORD, NY, Nov 17, 2009 -- Chembio Diagnostics, Inc. (OTCBB: CEMI), a company that develops, manufactures, licenses, and markets proprietary rapid diagnostic tests, announced today that it will present at a meeting of the Blood Products Advisory Committee ("BPAC") of the U.S. Food and Drug Administration ("FDA") in Bethesda, Maryland, on the afternoon of November 17, 2009. The agenda of the committee will include the public health need and performance characteristics of over-the-counter ("OTC") home-use HIV test kits.

About Chembio Diagnostics

Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $5 billion point-of-care testing market. Chembio's two FDA PMA-approved, CLIA-waived, rapid HIV tests are marketed in the U.S. by Inverness Medical Innovations, Inc. Chembio markets its HIV STAT-PAK(R) line of rapid HIV tests internationally to government and donor-funded programs directly and through distributors. Chembio has developed a patented point-of-care test platform technology, the Dual Path Platform (DPP(R)) technology, which has significant advantages over lateral-flow technologies. This technology is providing Chembio with a significant pipeline of business opportunities for the development and manufacture of new products based on DPP(R). Headquartered in Medford, NY, with approximately 100 employees, Chembio is licensed by the U.S. Food and Drug Administration (FDA) as well as the U. S. Department of Agriculture (USDA), and is certified for the global market under the International Standards Organization (ISO) directive 13.485.

ICP Solar Technologies Inc. (OTCBB:ICPR) trading at $0.095 per share on trading volume of 19,500 shares.

In a press release out on November 17, Energizer Licensees ICP Solar and Universal Power Group Join Forces

Joint Operations and Product Supply to Increase Sales

MONTREAL & CARROLLTON, Texas, Nov 17, 2009 -- ICP Solar Technologies Inc. (OTCBB:ICPR) (FWB:K1U), a developer and marketer of innovative solar panels, solar chargers, energy meters and other solar powered devices, today announced that it has partnered with Universal Power Group (NYSE Amex: UPG) in a third-party logistics and supply arrangement designed to leverage ICP Solar's broad product line and UPG's sourcing and distribution expertise.

About ICP Solar Technologies:

ICP Solar is a developer and marketer of solar panels, solar monitoring and power management solutions. Through the application of its own intellectual property and next-generation technologies, the Company aims to be the solar industry's innovation leader. For the past 20 years, ICP Solar has been a lead innovator in the consumer solar market and has now begun to apply that same innovation philosophy to the OEM, rooftop and power generation segment of the solar industry. ICP Solar's management has over 50 years of experience in the renewable energy sector. ICP Solar markets its products under its sunsei(R) brand and, in the solar charger category, is the global licensee of the Energizer(R) brand. The company's headquarters are located in Montreal, Canada, with an R&D center in St. John's, Canada and additional locations in the United States, Ireland, France and UK. Additional information may be found atwww.icpsolar.com, www.energizersolar.com and www.energizersolar.eu.

Vivakor, Inc. (OTC Bulletin Board: VIVK | Quote | Chart | News | PowerRating) trading at $0.54 on a volume of 215,349 shares

In a press release out on November 17, Vivakor, Inc. Announces Stock Dividend

CORALVILLE, Iowa, Nov 17, 2009 -- Vivakor, Inc. (OTC Bulletin Board: VIVK | Quote | Chart | News | PowerRating) today announced that its Board of Directors approved a dividend of shares of common stock of HealthAmerica, Inc., a Nevada corporation of which Vivakor owns approximately 84% of the outstanding common stock. Each Vivakor shareholder will be entitled to receive one share of HealthAmerica common stock for each share of Vivakor common stock beneficially owned on the record date. The record date for the distribution is expected to be December 1, 2009, subject to review and approval of FINRA, and the distribution date is expected to be December 9, 2009. After the dividend distribution, Vivakor will continue to own approximately 62% of the outstanding common stock of HealthAmerica.

About Vivakor, Inc.

Vivakor(TM) is a biomedical/biotechnology company with transdisciplinary research that develops and acquires products in the fields of molecular medicine, electro-optics, biological handling and natural and formulary compounds, that extend or improve life. More information can be found about Vivakor at www.vivakor.com.

Helix Wind Corp. (OTCBB: HLXW | Quote | Chart | News | PowerRating) trading at $2.84 on a volume of 16,005 shares

In a press release out on November 17, Helix Wind's S322 Turbine Helps Power School on Island of Malta

Second S322 unit to be installed by the Maltese Government this month

SAN DIEGO, Nov 17, 2009 -- Helix Wind Corp. (OTCBB: HLXW), a global renewable energy company, announced today that a model S322 wind turbine has withstood gale-force winds after being installed on a primary school on Malta, an island located in the Mediterranean Sea between Italy and Africa. Installed in September on the Pembroke Primary School, the turbine is part of a six-month test, which, if successful, could result in the installation of S322 turbines atop 40 other schools on the island.

About Helix: Helix Wind Corp., a global renewable energy company, is engaged in the design, manufacturing and sale of small wind vertical axis turbine designed to generate 300W, 1kW, 2.0kW, 4.0kW, and 50kW of clean, renewable electricity. Additional information can be found at http://www.helixwind.com.

Xtremepicks.com profiles early stage microcap and growth stocks that provide innovative products or services resulting in potentially "hyper-growth" opportunities. Often, these companies have yet to be recognized by Wall Street and the undiscovered nature of Xtremepicks.com's profile companies provide our members the opportunity to learn about these companies at their development stage, and more importantly before they possibly "turn the corner" and get exposed to a much larger investing audience.

Xtremepicks.com (www.Xtremepicks.com) has prepared all material herein based upon information believed to be reliable. The information contained herein is not guaranteed by Xtremepicks.com to be accurate, and should not be considered to be all-inclusive. Xtremepicks.com is a leading information resource for evaluating investment opportunities in small and microcap stocks. We focus on a limited number of companies in order to provide comprehensive coverage, including unique investment related features not available anywhere else on the Internet. To feature a company or to get more information, please visit us at www.Xtremepicks.com or email us at info@Xtremepicks.com Xtremepicks.coms affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event of a rise in value. Xtremepicks.com will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.

To view full disclaimers, go to http://www.Xtremepicks.com/disclaimer.htm

CONTACT: Xtremepicks.com
e-mail: Info@xtremepicks.com
WWW: http://www.Xtremepicks.com

((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.

For full details on (ICPRE) ICPRE. (ICPRE) has Short Term PowerRatings at TradingMarkets. Details on (ICPRE) Short Term PowerRatings is available at This Link.

For full details on (ICPR) ICPR. (ICPR) has Short Term PowerRatings at TradingMarkets. Details on (ICPR) Short Term PowerRatings is available at This Link.

For full details on (CEMI) CEMI. (CEMI) has Short Term PowerRatings at TradingMarkets. Details on (CEMI) Short Term PowerRatings is available at This Link.

For full details on (HLXW) HLXW. (HLXW) has Short Term PowerRatings at TradingMarkets. Details on (HLXW) Short Term PowerRatings is available at This Link.

For full details on (VIVK) VIVK. (VIVK) has Short Term PowerRatings at TradingMarkets. Details on (VIVK) Short Term PowerRatings is available at This Link.